![]() |
ScopePfizer CDI invites the Greek startup ecosystem to carve the future of healthcare through Digital Innovation with their visionary ideas in the second iteration of the Start4Health challenge. Through the challenge, Pfizer CDI aims to promote innovation and increase its engagement and collaboration with the local innovation ecosystem – creating mutually beneficial relationships. After a successful first run of the startup acceleration program in 2022, this year we seek a wider range of solutions, beyond digital healthcare and across the entire value chain of digital innovation in the pharmaceutical industry. |
Key ThematicsMore specifically, we seek solutions that fall under one or more of the following four thematic pillars: |
![]() |
3/5 – 26/5
2023
June – mid July
2023
Start4Health is addressed to all Greek startup companies of remarkable talent and skill and exceptional technology, products, services, and business models.
Teams that have a passion to shine, learn, and continuously improve, will co-create with us to achieve our purpose: breakthroughs that change patients’ lives.
More information on the terms and conditions
25.000€
Potential collaboration opportunities with Pfizer
10.000€
Potential collaboration opportunities with Pfizer
A judging committee of global and local experts in Technology, Innovation and Business, from both Pfizer and the ecosystem, will select the Top 5 startups to enter the acceleration phase.
During the acceleration phase, the Top 5 startups will have the chance to work with a dedicated global or local Pfizer Mentor and participate in various activities with experts to refine their technology, products, and services, sharpen their business model and maximize their value proposition.
In the final pitch day, the judges will decide the Top 2 winners with the most competitive pitches after the acceleration phase to win monetary prizes. All startups that manage to create an alluring business case, have a chance to score a collaboration with Pfizer CDI.
The start4health challenge will open on May 3rd, 2023.
The final deadline for submissions is May 26, 2023 (11:59 pm EET).
Nico Gariboldi - Vice President, Thessaloniki Site Lead
Thanos Stavropoulos - Sr. Manager, Technology & Innovation, Pfizer CDI
Thomas Kareklas – Sr. Manager, Technology & Innovation, Pfizer CDI
Athina Stergiou – Director, Principal Engineer, Pfizer
Ioanna Vasdeki – Experience Design Engineer, Pfizer
Theo Anagnostopoulos - General Manager, SciCo
Filippos Zakopoulos - Managing Partner, Found.ation
Namita Mittal Pande – Director, Digital Innovation and Strategist, Pfizer
Gati Dharani,
Director, Digital Strategy and Data Innovation, Pfizer
Tamara Mansfeld – Sr. Director Team Leader, Pfizer Digital & Alliances
Vasilis Tsekouras – Global Medical Director Enbrel, Global Medical Affairs, Pfizer Inflammation & Immunology
Vasilis Tzinieris – Hospital Lead Greece Region, Pfizer Hellas
Natalie Danti – EM GTM transformation Lead, Pfizer
The challenge will last approximately three months, including three consecutive phases: the Open Call, the Acceleration Phase, and the Final Picth Day.
The Top 5 startups will enter the Acceleration Phase for six weeks and will be assisted by Pfizer Mentors and Coaches from the ecosystem.
The Final Pitch Day includes pitches, events, and awards of the Top 2 startups.
03/05/2023
-
26/05/2023
end of May 2023
Beginning of June 2023
June
-
mid July 2023
mid July 2023
SUBSCRIBE TO OUR NEWSLETTER